Williams Lewis T Insider Trades

Insider Trading History

Track insider trading activity for Williams Lewis T. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $931k 7,825 shares
Last Trade
Feb 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.48M 18,000 shares
$82.42
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $3.07M 25,825 shares
Last Trade
Feb 17, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.97M 36,000 shares
$82.46
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $931k 7,825 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$563k 6,457 shares
$87.18
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $783k 6,584 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$257k 6,584 shares
$38.98
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $3.06M 25,700 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$602k 25,700 shares
$23.42
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $3.57M 30,000 shares
Last Trade
Jan 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$365k 30,000 shares
$12.17
$118.96
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $2.38M 20,000 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$166k 20,000 shares
$8.31
$118.96
Arcellx
Arcellx ACLX
Director
Holding Value $241M 2,095,114 shares
Last Trade
Feb 08, 2022 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$37.3M 2,095,114 shares
$17.78
$115.07
Arcellx
Arcellx ACLX
Director
Holding Value $0 0 shares
Last Trade
Feb 08, 2022 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$37.3M 2,095,114 shares
$17.78
$115.07
Arcellx
Arcellx ACLX
Director
Holding Value $0 0 shares
Last Trade
Feb 03, 2022 Sale
No data
No data
$115.07
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $2.14M 18,000 shares
Last Trade
May 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$634k 18,000 shares
$35.23
$118.96
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Director
Holding Value $87.3k 25,000 shares
Last Trade
May 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $1.78M 15,000 shares
Last Trade
May 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$248k 15,000 shares
$16.54
$118.96
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Director
Holding Value $87.3k 25,000 shares
Last Trade
May 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Director
Holding Value $76.8k 22,000 shares
Last Trade
Oct 10, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Five Prime Therapeutics
Five Prime Therapeutics FPRX
Director
Holding Value $17.3M 455,336 shares
Last Trade
Sep 01, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$38.1k 7,024 shares
$5.43
$38.00
Five Prime Therapeutics
Five Prime Therapeutics FPRX
Director
Holding Value $570k 15,000 shares
Last Trade
Jun 10, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.4k 15,000 shares
$6.09
$38.00
Protagonist Therapeutics
Protagonist Therapeutics PTGX
Director
Holding Value $1.43M 12,000 shares
Last Trade
Jun 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 12,000 shares
$11.80
$118.96
Five Prime Therapeutics
Five Prime Therapeutics FPRX
Director
Holding Value $17.5M 461,360 shares
Last Trade
Feb 26, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.1k 926 shares
$11.95
$38.00
Five Prime Therapeutics
Five Prime Therapeutics FPRX
Director
Holding Value $17.6M 462,360 shares
Last Trade
Feb 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.6k 7,400 shares
$11.97
$38.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up